melanoma

📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma

By |2026-01-15T21:39:21+00:00January 15, 2026|CCKP, Data Features|

Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]

Comments Off on 📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma

Featured Dataset: Transcriptional dysregulation of BAHCC1 in melanoma [Cut & Tag]

By |2024-06-10T19:01:55+00:00June 19, 2024|CCKP|

Cut&Tag sequencing data from melanoma cells revealed that BAHCC1, a gene associated with Super-Enhancers (SE) and critical for cancer growth, is highly active compared [...]

Comments Off on Featured Dataset: Transcriptional dysregulation of BAHCC1 in melanoma [Cut & Tag]
Go to Top